30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

GEMAYEL GEORGES

Insider profile

Performance

Overall performance
2.6

Performance over holding periods
2.6
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 43% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
GEMAYEL GEORGES's trades of Supernus Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-09 2026-03-06 S Sale
31,826 +12.4%
419.81
US$487,309
31,826 +12.4% 419.81 US$487,309
2026-03-06 2026-03-06 PrS Proposed sale
2,251
26.25
US$1,740,395
2,251 26.25 US$1,740,395
2026-03-09 2026-03-05 S Sale
48,334 -12.4%
284.03
US$3,148,003
48,334 -12.4% 284.03 US$3,148,003
2026-03-05 2026-03-05 PrS Proposed sale
10,000
53.71
US$537,117
10,000 53.71 US$537,117
2024-11-12 2024-11-08 S Sale
10,787 -44.8%
36.30
US$391,568
10,787 -44.8% 36.30 US$391,568
2024-11-08 2024-11-08 PrS Proposed sale
10,787
36.30
US$391,536
10,787 36.30 US$391,536
2024-11-08 2024-11-07 S Sale
14,213 -51.6%
36.62
US$520,480
14,213 -51.6% 36.62 US$520,480
2024-11-07 2024-11-07 PrS Proposed sale
14,213
36.62
US$520,511
14,213 36.62 US$520,511
2024-09-17 2024-09-13 S Sale
10,000 -42.9%
31.33
US$313,300
10,000 -42.9% 31.33 US$313,300
2024-09-17 2024-09-13 S Sale
3,886 -22.6%
31.33
US$121,748
3,886 -22.6% 31.33 US$121,748
2024-09-13 2024-09-13 PrS Proposed sale
13,886
31.33
US$435,041
13,886 31.33 US$435,041
2020-08-07 2020-08-05 PlS Planned sale
10,000 -41.5%
33.00
US$330,000
10,000 -41.5% 33.00 US$330,000
2020-07-30 2020-07-29 PlS Planned sale
10,000 -41.5%
30.00
US$300,000
10,000 -41.5% 30.00 US$300,000